Incidence of urological complications in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first line abiraterone and enzalutamide
Lorca Alvaro, J., Serrano Domingo, J.J., Álvarez Rodriguez, S., Alonso Gordoa, T., López Campos, F., Rodriguez-Patrón, R., Gajate Borau, P., Brasero Burgos, J., Laso Garcia, I., Carrato Mena, A., BurgVolume:
17
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)33738-2
Date:
November, 2018
Fichier:
PDF, 76 KB
2018
File converter
Plus de résultats de recherche
More benefits 
